| Literature DB >> 23747225 |
Yanming Du1, Hong Ye, Fang Guo, Lijuan Wang, Tina Gill, Noshena Khan, Andrea Cuconati, Ju-Tao Guo, Timothy M Block, Jinhong Chang, Xiaodong Xu.
Abstract
Novel N-alkyldeoxynojirimycins (NADNJs) based on our previous lead 3 were designed, synthesized and tested in metabolic assays and in virus cultures. NADNJs containing terminal tertiary benzamide, sulfonamide, urea, and oxazolidinone moieties were discovered to have improved metabolic stability compared to 3, while maintaining submicromolar EC50 against BVDV and Tacaribe virus; and low cytotoxicity.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23747225 DOI: 10.1016/j.bmcl.2013.04.052
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823